Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

The Auphians it appears do not have all the answers:

$6.75 was the offering price for 26 million shares. That is a HUGE number of shares out of 83 million shares. If it was me, I would watch $6.75 like a hawk...

VICTORIA, British Columbia--(BUSINESS WIRE)--

Aurinia Pharmaceuticals Inc. (AUPH) (AUP.TO) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology market, today announced the closing of its previously announced underwritten public offering of 25,645,000 common shares, including 3,345,000 common shares pursuant to the full exercise of the underwriters’ option to purchase additional common shares (the “Offering”). The shares were sold at a public offering price of US$6.75 per share. The gross offering proceeds to the Company from this Offering are approximately US$173.1 million, before deducting underwriting discounts and commissions and other estimated offering expenses